Aurelia Private Equity is an institutional investor (Conventional VCs) founded in 2003 and headquartered in Frankfurt Am Main, Germany. Aurelia Private Equity is an early-stage venture capital firm. Makes investments in territories such as Germany, Singapore, and the UK. Typically invests in life sciences and tech companies operating in sectors like Gaming, SaaS, Biopharma, and Diagnostics. Notable investments include Bigpoint, Gilupi, MerLion Pharmaceuticals, Hematris. Usually, invests €0.5M to $3M in companies. Notable portfolio companies: Bigpoint, Gilupi, MerLion Pharmaceuticals, Hematris.

Stage

seed, early-stage venture, Series A, Series C, growth, seed, early-stage venture, Series A, Series C, growth

Check size

$3M-$7M

HQ

Frankfurt Am Main, Germany

Founded

2003

Website

http://aurelia-pe.de

LinkedIn

https://linkedin.com/company/aurelia-private-equity-gmbh

What they look for

German companies; excellent/experienced management; scalable products with technological advantage and clear competitive advantages; high scaling potential

Preparing to pitch Aurelia Private Equity?

CrackTheDeck analyzes your pitch deck before the meeting — structure, narrative, investor fit.